KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Graftech International (EAF) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Graftech International (EAF) over the last 8 years, with Q4 2025 value amounting to $12.0 million.

  • Graftech International's Asset Writedowns and Impairment fell 766.33% to $12.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $18.4 million, marking a year-over-year decrease of 2614.86%. This contributed to the annual value of $18.3 million for FY2025, which is 2644.58% down from last year.
  • Graftech International's Asset Writedowns and Impairment amounted to $12.0 million in Q4 2025, which was down 766.33% from $1.7 million recorded in Q3 2025.
  • In the past 5 years, Graftech International's Asset Writedowns and Impairment ranged from a high of $13.0 million in Q4 2024 and a low of $1.4 million during Q2 2024
  • In the last 3 years, Graftech International's Asset Writedowns and Impairment had a median value of $2.8 million in 2025 and averaged $6.2 million.
  • The largest annual percentage gain for Graftech International's Asset Writedowns and Impairment in the last 5 years was 3758.15% (2025), contrasted with its biggest fall of 7832.46% (2025).
  • Graftech International's Asset Writedowns and Impairment (Quarter) stood at $12.4 million in 2023, then increased by 4.45% to $13.0 million in 2024, then fell by 7.66% to $12.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $12.0 million for Q4 2025, versus $1.7 million for Q3 2025 and $1.9 million for Q2 2025.